Fig. 2From: Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological reviewDelay between primary trial completion day and availability of results from sources in days. CSR, clinical study report; CT, ClinicalTrials.gov; ECTR, European Clinical Trials RegisterBack to article page